Company intelligence / Profile preview

CDG

Thousand Oaks, California, United Statesparisaeroport.fr ↗

Ownership: Public · 2487
Development stage: Other

Overview

CDG Biotech develops and manufactures automated esoteric IVD diagnostic solutions. Their flagship product line is the Q-Strip® series of solid-phase immunoassays for quantitative measurement of hormones and biomarkers. These are available in a single-use cartridge format to minimize user intervention. The company is ISO 13485 certified and FDA registered, with distribution across North America, Europe, and Latin America. No clinical trial results are reported as the products are diagnostics rather than therapeutics.

Therapeutic areas: Endocrinology
Modalities: Solid-phase immunoassayDiagnostic device
Industry: Metabolite Diagnostics

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on CDG.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CDG.

Explore the full profile